Analystreport

LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

LogicBio Therapeutics, Inc.  (LOGC) 
Last logicbio therapeutics, inc. earnings: 8/13 08:00 am Check Earnings Report